Oritavancin

Tenkasi 1200 mg poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 19 Mar 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

Tenkasi (previously Orbactiv)European UnionAuthorised

Tenkasi (previously Orbactiv)European Union · Menarini International Operations Luxembourg S.A.Same brand
TenkasiCroatiaSame brand
TenkasiItaly · Polvere per concentrato per soluzione per infusione · Menarini International Operations Luxembourg S.A.Same brand
OritinivCanada · 400 MG / VIAL · Powder For Solution · Xediton Pharmaceuticals INCSame substance
OritinivCanada · 1200 MG / VIAL · Powder For Solution · Xediton Pharmaceuticals INCSame substance
RamvocidEuropean Union · Targanta Netherlands B.V.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Oritavancin

Tenkasi 1200 mg poeder voor concentraat voor oplossing voor infusie

Poeder voor concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 19 Mar 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

Tenkasi (previously Orbactiv)European UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

OrbactivSaudi Arabia · Patheon Italia S.P.A.

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Oritavancin
Dosage form: Poeder voor concentraat voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 19 Mar 2015
Registration: EU/1/15/989
Marketing authorisation holder: Menarini International Operations Luxembourg S.A.
ATC code: J01XA05
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/003785
EU number: EU/1/15/989